Arcutis Biotherapeutics Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen. It's my pleasure to welcome you to the 2026 Annual Meeting of Stockholders of Arcutis Biotherapeutics, Inc. I'm Frank Watanabe, the President and Chief Executive Officer of Arcutis.
In accordance with our bylaws, I will act as the Chairperson of this meeting. [John Holway] from Broadridge Financial Solutions is with us today and will act as Inspector of Election. I have been advised by our Inspector of Election that 86.46% of the shares of common stock are represented virtually or by proxy and that a quorum is present. The meeting is now called to order, and we will follow the rules of conduct and order of business of the meeting as listed in the program posted on the virtual meeting website.
Before we begin with the formalities of the Annual Meeting, I would like to introduce to you other team members who have joined me for the meeting. Latha Vairavan, our Chief Financial Officer; Mas Matsuda, our Chief Legal Officer and Corporate Secretary of this meeting; and Brian
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
